KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Gains from Investment Securities (2016 - 2025)

Cvs Health's Gains from Investment Securities history spans 13 years, with the latest figure at -$832.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities fell 146.79% year-over-year to -$832.0 million, compared with a TTM value of $336.0 million through Dec 2025, down 80.27%, and an annual FY2025 reading of $336.0 million, down 80.27% over the prior year.
  • Gains from Investment Securities for Q4 2025 was -$832.0 million at Cvs Health, down from $1.0 billion in the prior quarter.
  • The five-year high for Gains from Investment Securities was $3.3 billion in Q4 2021, with the low at -$2.7 billion in Q4 2023.
  • Average Gains from Investment Securities over 5 years is $488.5 million, with a median of $63.0 million recorded in 2024.
  • Year-over-year, Gains from Investment Securities crashed 356.6% in 2023 and then soared 7053.33% in 2025.
  • Tracing CVS's Gains from Investment Securities over 5 years: stood at $3.3 billion in 2021, then tumbled by 68.21% to $1.0 billion in 2022, then crashed by 356.6% to -$2.7 billion in 2023, then surged by 166.24% to $1.8 billion in 2024, then plummeted by 146.79% to -$832.0 million in 2025.
  • Per Business Quant, the three most recent readings for CVS's Gains from Investment Securities are -$832.0 million (Q4 2025), $1.0 billion (Q3 2025), and $114.0 million (Q2 2025).